MANHARD KIMBERLY — SEC insider filings

SEC reporting owner CIK 1202094. 28 insider filings on record with FilingPulse; latest filed 2026-09-18.

Transaction summary — filings shown

Covers all 28 filings on record, filed 2020-08-21 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Inhibrx Biosciences, Inc. (INBX)Director71 leg · 10,000 sh · $139,8005 legs · 2,500 sh · $279,0104
HERON THERAPEUTICS, INC. /DE/ (HRTX)EVP, Drug Development16—3 legs · 13,033 sh · $234,16253
Inhibrx, Inc. (INBX)Director5——9

Insider filings — MANHARD KIMBERLY

FiledFormIssuerReported transactionsSource
2026-09-184/AInhibrx Biosciences, Inc. (INBX)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2026-09-154Inhibrx Biosciences, Inc. (INBX)Sale (S): 500 @ $111.78 · Sale (S): 500 @ $110.26 · Sale (S): 500 @ $105.05EDGAR
2026-09-104Inhibrx Biosciences, Inc. (INBX)Sale (S): 500 @ $115.14 · Sale (S): 500 @ $115.80EDGAR
2026-06-044Inhibrx Biosciences, Inc. (INBX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2025-05-294Inhibrx Biosciences, Inc. (INBX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2024-08-304Inhibrx Biosciences, Inc. (INBX)Purchase (P): 10,000 @ $13.98EDGAR
2024-05-304Inhibrx Biosciences, Inc. (INXB)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-05-304Inhibrx, Inc. (INBX)Disposition to issuer (D): 3,500 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 17,259 (derivative)EDGAR
2023-05-304Inhibrx, Inc. (INBX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2023-04-174HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 1,417 @ $2.88 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0EDGAR
2023-01-204HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 149,365 (derivative) @ $0EDGAR
2023-01-174HERON THERAPEUTICS, INC. /DE/ (HRTX)Other (J): 1,655 @ $3.27 · Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $3.17 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0EDGAR
2022-10-174HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $3.76 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0EDGAR
2022-07-274HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 165,961 (derivative) @ $0EDGAR
2022-07-154HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $3.01 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0EDGAR
2022-05-264Inhibrx, Inc. (INBX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2022-05-044HERON THERAPEUTICS, INC. /DE/ (HRTX)Other (J): 1,504 @ $3.84 · Sale (S): 1,504 @ $4.76EDGAR
2022-04-154HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $6.07 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0EDGAR
2022-01-144HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $8.30 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0EDGAR
2021-10-154HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 1,250 · Tax withholding (F): 433 @ $10.55 · Option exercise (M): 1,250 (derivative) @ $0 · Grant/award (A): 92,200 (derivative) @ $0 · Grant/award (A): 55,320 (derivative) @ $0EDGAR
2021-07-154HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 1,250 · Tax withholding (F): 433 @ $13.48 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2021-06-084Inhibrx, Inc. (INBX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-05-044HERON THERAPEUTICS, INC. /DE/ (HRTX)Other (J): 1,529 @ $13.90 · Sale (S): 1,529 @ $17.66EDGAR
2021-04-154HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 1,250 · Tax withholding (F): 433 @ $16.66 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2021-01-154HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 1,250 · Tax withholding (F): 433 @ $18.16 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2020-12-234HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 10,000 @ $13 · Sale (S): 10,000 @ $20 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2020-10-154HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 120,000 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2020-08-214Inhibrx, Inc. (INBX)Grant/award (A): 17,259 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1202094 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs